44 7897 074717Short Communication - Journal of Pharmaceutical Chemistry & Chemical Science (2025) Volume 9, Issue 4
Natural products: Advancing drug discovery & delivery.
Priya Deshmukh*
Department of Pharmaceutical Sciences, Jawaharlal Nehru University, India
- *Corresponding Author:
- Priya Deshmukh
Department of Pharmaceutical Sciences
Jawaharlal Nehru University, India.
E-mail: priya.deshmukh@jnu.ac.in
Received : 04-Sep-2025, Manuscript No. AAPCCS-25-198; Editor assigned : 08-Sep-2025, PreQC No. AAPCCS-25-198(PQ); Reviewed : 26-Sep-2025, QC No AAPCCS-25-198; Revised : 07-Oct-2025, Manuscript No. AAPCCS-25-198(R); Published : 16-Oct-2025 , DOI : 10.35841/aapccs-9.4.198
Citation: Deshmukh P. Natural products: Advancing drug discovery & delivery. J Pharm Chem Chem Sci. 2025;09(04):198.
Introduction
Natural products are critically important as a rich reservoir for discovering new drugs, with recent technological advancements significantly improving methods for their isolation, characterization, and screening. Their potential to address unmet medical needs is substantial, and the integration of bioinformatics and Artificial Intelligence promises to accelerate this entire process, even with known challenges in pharmacokinetics and biopharmaceutics [1].
Enhancing the oral bioavailability of natural products presents a significant challenge in their pharmaceutical development. To tackle this, various innovative formulation approaches are being explored, such as nanoformulations, co-crystals, and self-emulsifying drug delivery systems. These strategies aim to overcome the inherent poor solubility and permeability issues found in many natural compounds [2].
Understanding the pharmacokinetics and potential drug-drug interactions involving natural products is crucial. An in-depth analysis of absorption, distribution, metabolism, and excretion profiles, alongside enzyme inhibition or induction, is essential to ensure both safety and efficacy when these natural compounds are used concurrently with conventional medicines [3].
In the field of cancer research, recent advancements show promising utilization of natural products for developing novel anticancer agents. This includes delving into various classes of natural compounds that demonstrate potent cytotoxic and anti-proliferative activities. Researchers are discussing their mechanisms of action and outlining strategies to overcome drug resistance, ultimately working towards improving therapeutic outcomes in cancer treatment [4].
What this really means is that a crucial aspect of drug discovery involving natural products is the identification of their targets and the elucidation of their mechanisms of action. This involves employing various experimental and computational approaches, like chemical biology tools and phenotypic screening. The goal is to pinpoint specific molecular targets and pathways modulated by these natural compounds, thereby accelerating their development into effective therapeutic agents [5].
Nanotechnology plays a significant role in developing advanced delivery systems for natural products. This includes various nanocarriers such as liposomes, nanoparticles, and polymeric micelles. These systems can enhance solubility, improve stability, facilitate targeted delivery, and improve overall biopharmaceutical properties of natural compounds, leading to enhanced therapeutic efficacy [6].
Here's the thing: the emerging field of pharmacogenomics applied to natural products is exploring how genetic variations can influence individual responses to these compounds. This interdisciplinary approach holds potential to bridge traditional medicine practices with personalized healthcare, ultimately optimizing efficacy and minimizing adverse effects based on an individual's unique genetic makeup [7].
Natural products also play a significant role as a source for novel antiviral agents, which is particularly relevant given emerging infectious diseases. Research discusses various mechanisms of action, ranging from inhibiting viral replication to boosting host immunity. Recent successes and strategies in drug discovery are examined for developing effective natural product-derived antivirals [8].
Advances in Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADME/Tox) profiling of natural products are critical for their successful drug development. This involves various in vitro, in vivo, and in silico methods used to predict the pharmacokinetic and toxicological properties of these compounds, ensuring their safe and effective progression in development pipelines [9].
Lastly, biopharmaceutical challenges such as poor solubility, low permeability, and extensive first-pass metabolism are extensively analyzed when it comes to natural products. To overcome these hurdles, various advanced formulation strategies are being discussed, including nanotechnology, cyclodextrin complexation, and lipid-based systems, all designed to enhance the bioavailability and therapeutic efficacy of these valuable compounds [10].
Conclusion
Natural products stand as a crucial reservoir for discovering new drugs, driven by continuous advancements in isolation, characterization, and screening technologies. They offer substantial potential to address unmet medical needs, a process increasingly accelerated by integrating bioinformatics and Artificial Intelligence. However, inherent challenges such as poor pharmacokinetics and biopharmaceutics, including low solubility, permeability, and extensive first-pass metabolism, necessitate innovative solutions. Significant efforts are underway to enhance oral bioavailability through advanced formulation strategies like nanoformulations, co-crystals, and self-emulsifying drug delivery systems. Comprehensive understanding of pharmacokinetics, Absorption, Distribution, Metabolism, Excretion, and Toxicity profiling, alongside potential drug-drug interactions, is paramount for ensuring both safety and efficacy, especially when natural compounds are co-administered with conventional medicines. Research also critically focuses on identifying specific molecular targets and elucidating mechanisms of action through various experimental and computational approaches. Beyond these fundamental aspects, natural products are proving invaluable in specific therapeutic areas, such as the development of novel anticancer and antiviral agents, with ongoing work to understand their diverse mechanisms and strategies to overcome resistance. The application of nanotechnology further refines drug delivery systems, improving stability and targeted action. Moreover, the emerging field of pharmacogenomics aims to personalize natural product therapies by considering individual genetic variations, bridging traditional practices with modern healthcare. Together, these areas highlight a concerted, multidisciplinary approach to harness the full therapeutic potential of natural products.
References
References
- Md. SH, Md. II, Md. SH. Natural products as a valuable source for drug discovery: Recent advancements and future perspectives. J Ethnopharmacol. 2023;308:116246.
Indexed at, Google Scholar, Crossref
- Qing Y, Lin L, Yan-Yan S. Recent advances in biopharmaceutics of natural products: Strategies to improve oral bioavailability. J Pharm Sci. 2022;111(10):10.
Indexed at, Google Scholar, Crossref
- Feng-Lin L, Juan L, Hong-Liang X. Pharmacokinetics and drug interaction studies of natural products: A comprehensive review of recent advances. Front Pharmacol. 2023;14:1311039.
Indexed at, Google Scholar, Crossref
- Muhammad NA, Muhammad SI, Syeda SS. Natural products as sources of anticancer agents: recent developments in drug discovery. Phytochemistry Rev. 2023;None:None.
Indexed at, Google Scholar, Crossref
- Chun-Qiu L, Qian W, Yun-Zhu D. Target Identification and Mechanism of Action Studies of Natural Products in Drug Discovery. Med Res Rev. 2022;42(6):None.
Indexed at, Google Scholar, Crossref
- Amir Z, Hamed M, Elham G. Nanotechnology-Based Delivery Systems for Natural Products: Recent Advances and Biopharmaceutical Applications. ACS Biomater Sci Eng. 2021;7(8):None.
Indexed at, Google Scholar, Crossref
- Zaid A, Ammar A, Ghalib A. Pharmacogenomics of Natural Products: A Bridge between Traditional Medicine and Personalized Healthcare. Front Pharmacol. 2020;11:575023.
Indexed at, Google Scholar, Crossref
- Jing Z, Xiao-Dong Y, Guang-Yong L. Natural Products as Antiviral Agents: Recent Insights and Drug Discovery Strategies. Phytother Res. 2021;35(1):None.
Indexed at, Google Scholar, Crossref
- Bing-Nan Z, Li D, Chun-Qiu L. Advances in ADME/Tox Profiling of Natural Products for Drug Development. Planta Med. 2022;88(1):None.
Indexed at, Google Scholar, Crossref
- Naila R, Muhammad TI, Kazi MR. Formulation strategies to overcome challenges in natural product biopharmaceutics: A review. Curr Pharm Des. 2023;29(21):None.